PainReform to Present at the Microcap Conference in Atlantic City
Tel Aviv, Israel--(Newsfile Corp. - January 22, 2024) - PainReform Ltd. (NASDAQ: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that management will be participating at The Microcap Conference which is being held on January 30 - February 1, 2024 at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ.
- Tel Aviv, Israel--(Newsfile Corp. - January 22, 2024) - PainReform Ltd. (NASDAQ: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that management will be participating at The Microcap Conference which is being held on January 30 - February 1, 2024 at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ.
- Ilan Hadar, CEO of the Company is scheduled to present on Wednesday, January 31st at 10:50 AM EST in Track 2 and Thursday, February 1st at 10:25 AM EST in Track 5.
- Management will also be participating in one-on-one meetings with qualified investors throughout the conference.
- To register to attend The Microcap Conference, please follow this link .